Wei Shuanzeng, Al-Saleem Tahseen
Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA, USA.
J Kidney Cancer VHL. 2017 May 22;4(2):19-23. doi: 10.15586/jkcvhl.2017.70. eCollection 2017.
Sarcomatoid renal cell carcinoma is a highly aggressive tumor. It is not a distinct histologic entity as it can be found in any subtypes of renal cell carcinoma. Recent molecular and genetic evidence suggest that sarcomatoid component is transformed from a common progenitor of the associated renal cell carcinoma, and the TP53 gene plays a pivotal role in this process. The presence of sarcomatoid carcinoma indicates poor prognosis, which also correlates with the amount of the sarcomatoid component. Therefore, the presence and quantity of sarcomatoid component should be reflected in pathology reports. However, pathology reporting seems to vary among laboratories prompting the need for a unified reporting system. We propose a pathology reporting system similar to that of transformed follicular lymphoma that is consistent with the molecular pathogenesis to ensure uniform reporting.
肉瘤样肾细胞癌是一种侵袭性很强的肿瘤。它并非一种独特的组织学实体,因为它可见于肾细胞癌的任何亚型中。最近的分子和遗传学证据表明,肉瘤样成分是从相关肾细胞癌的共同祖细胞转化而来的,并且TP53基因在这一过程中起关键作用。肉瘤样癌的存在预示着预后不良,这也与肉瘤样成分的数量相关。因此,肉瘤样成分的存在和数量应在病理报告中体现出来。然而,不同实验室之间的病理报告似乎存在差异,这就促使需要一个统一的报告系统。我们提出一种类似于转化型滤泡性淋巴瘤的病理报告系统,该系统与分子发病机制相一致,以确保报告的一致性。